Boston Scientific Clears FDA Hurdle for Asurys Fluid Management System
Event summary
- Boston Scientific received FDA 510(k) clearance for the Asurys™ Fluid Management System on March 30, 2026.
- The system is designed to manage irrigation and intrarenal pressure (IRP) during endoscopic urologic procedures.
- Asurys integrates with the LithoVue™ Elite Ureteroscope for real-time IRP monitoring and automatic irrigation control.
- Limited U.S. market release of the device will begin in the coming days.
The big picture
Boston Scientific's FDA clearance for the Asurys System strengthens its position in the urology market, particularly in kidney stone management. The integration with existing StoneSmart Solutions products highlights the company's strategy of building an ecosystem of interoperable devices. This move comes amid growing industry focus on minimizing procedural risks and improving efficiency in endoscopic urologic procedures.
What we're watching
- Market Adoption
- The pace at which the Asurys System gains traction among urologists and hospitals will determine its commercial success.
- Competitive Response
- How competitors like Olympus and Richard Wolf react to this innovation could shape the urology device market.
- Clinical Impact
- Whether the system's IRP management capabilities translate into measurable improvements in patient outcomes.